About RapidAI
RapidAI is a company based in San Mateo (United States) founded in 2012 by Greg Albers. RapidAI has raised $100 million across 2 funding rounds from investors including Vista Credit Partners and Lennertz & Co. RapidAI has completed 1 acquisition, including EndoVantage. RapidAI offers products and services including Rapid NCCT, Rapid ICH, Rapid PE Analytics, and RapidAI for Aneurysm. RapidAI operates in a competitive market with competitors including Viz.ai, Qure.ai, Subtle Medical, Perspectum and Zebra Medical Vision, among others.
- Headquarter San Mateo, United States
- Founders Greg Albers
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ischemaview, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$100 M (USD)
in 2 rounds
-
Latest Funding Round
$75 M (USD), Series C
Jul 20, 2023
-
Investors
Vista Credit Partners
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RapidAI
RapidAI offers a comprehensive portfolio of products and services, including Rapid NCCT, Rapid ICH, Rapid PE Analytics, and RapidAI for Aneurysm.
AI tool for analyzing non-contrast CT scans for stroke indicators.
Software for identifying intracranial hemorrhage in medical imaging.
Platform for quick detection of pulmonary embolism cases.
AI system to track and treat aneurysms using imaging data.
People of RapidAI
Unlock access to complete
Unlock access to complete
Funding Insights of RapidAI
RapidAI has successfully raised a total of $100M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $75 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in RapidAI
RapidAI has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Vista Credit Partners and Lennertz & Co.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Wealth management and investment services are provided by Lennertz & Co.
|
Locked | Locked | Locked | |
|
Credit financing is provided to enterprise software and technology businesses.
|
Locked | Locked | Locked |
Investor details for RapidAI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RapidAI
RapidAI has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include EndoVantage.
Investment portfolio details for RapidAI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Personalized endovascular treatment planning solutions are developed.
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for RapidAI
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - RapidAI
Detailed financials for RapidAI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rapidai Comparisons
Peer comparison for RapidAI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RapidAI
RapidAI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viz.ai, Qure.ai, Subtle Medical, Perspectum and Zebra Medical Vision, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| Locked | Locked | Locked |
AI-powered solutions for medical imaging diagnostics
|
|
| Locked | Locked | Locked |
AI-driven solutions for medical diagnostic imaging are developed.
|
|
| Locked | Locked | Locked |
Precision medicine software for liver disease diagnosis is offered.
|
|
| Locked | Locked | Locked |
Provider of AI and SaaS-based medical image based decision support tools
|
|
| Locked | Locked | Locked |
Provide contract research imaging services and software
|
Detailed competitors of RapidAI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rapidai
Complete news archive for RapidAI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RapidAI
RapidAI was founded in 2012 and raised its 1st funding round 8 years after it was founded.
RapidAI is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Karim Karti is the current CEO of RapidAI.
RapidAI is a funded company, having raised a total of $100M across 2 funding rounds to date.
RapidAI is the platform offering many AI-based neuroimaging software used by physicians in clinical diagnosis and treatment. The different products offered are Rapid MRI, Rapid CTA, Rapid CTP, Rapid ICH that use AI technology to provide good quality images from the non-contrast images and scans. Rapid mobile app provided in the platform is used for communication about patient care.
RapidAI's top competitors include Perspectum, Qure.ai and Subtle Medical.
RapidAI offers Rapid NCCT, Rapid ICH, Rapid PE Analytics, and RapidAI for Aneurysm.
RapidAI has made 1 acquisition, including EndoVantage.
RapidAI has 2 investors. Key investors include Vista Credit Partners, and Lennertz & Co.